AMRI Files New Patent Infringement Lawsuits against Dr. Reddy's Laboratories (RDY) and Sandoz
Up)
AMRI (NASDAQ: AMRI) announced that it has filed two new patent infringement lawsuits in U.S. District Court in New Jersey against Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories (NYSE: RDY) and Sandoz, Inc. for infringement of AMRI's U.S. Patent Number 7,390,906. The recently issued patent relates to the manufacturing process for the active ingredient in sanofi-aventis's Allegra(R) and Allegra(R)D drug products.
This legal action relates to generic versions of sanofi-aventis's Allegra(R) and Allegra(R)D drug products for which the defendants are seeking or have obtained marketing approval from the FDA and which the defendants have marketed in the United States.
This legal action relates to generic versions of sanofi-aventis's Allegra(R) and Allegra(R)D drug products for which the defendants are seeking or have obtained marketing approval from the FDA and which the defendants have marketed in the United States.
You May Also Be Interested In
- Syngenta (SYT) settles atrazine litigation; will pay $105M in deal
- eBay's (EBAY) PayPal, VeriFone (PAY) Enter Licensing Deal; EBAY Moving Higher
- Proctor & Gamble (PG) To Change 'Tide Pods' Design So Kids Don't Eat Them
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
